124 related articles for article (PubMed ID: 8690179)
1. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland.
Huang X; Orho M; Lehto M; Groop L
Diabetologia; 1995 Oct; 38(10):1246-8. PubMed ID: 8690179
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population.
Ambrosch A; Lobmann R; Dierkes J; König W; Luley C; Lehnert H
Clin Chem Lab Med; 1999 Jul; 37(7):719-21. PubMed ID: 10510728
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population.
Babadjanova G; Reincke M; Mora P; Chuchalin A; Allolio B
Exp Clin Endocrinol Diabetes; 1997; 105(4):225-6. PubMed ID: 9285210
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus.
Fujisawa T; Ikegami H; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Fukuda M; Ogihara T
Diabetologia; 1995 Aug; 38(8):983-5. PubMed ID: 7589886
[TBL] [Abstract][Full Text] [Related]
5. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study Group.
Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Maioli M; Pala G; Massidda A; Manai M; Pilosu RM; Li LS; Luthman H; Maioli M
Diabetologia; 1997 Jan; 40(1):89-94. PubMed ID: 9028723
[TBL] [Abstract][Full Text] [Related]
6. Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance.
Odawara M; Tachi Y; Yamashita K
Hum Genet; 1996 Dec; 98(6):636-9. PubMed ID: 8931690
[TBL] [Abstract][Full Text] [Related]
7. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus.
Hager J; Hansen L; Vaisse C; Vionnet N; Philippi A; Poller W; Velho G; Carcassi C; Contu L; Julier C
Nat Genet; 1995 Mar; 9(3):299-304. PubMed ID: 7773293
[TBL] [Abstract][Full Text] [Related]
8. Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients.
Odawara M; Matsunuma A; Yamashita K
Diabetes Care; 1996 May; 19(5):547. PubMed ID: 8732726
[No Abstract] [Full Text] [Related]
9. [Gly40Ser mutation of glucagon receptor gene and NIDDM in Han nationality].
Deng H; Tang WL; Pan Q
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):291-3. PubMed ID: 12536714
[TBL] [Abstract][Full Text] [Related]
10. Restricted geographical extension of the association of a glucagon receptor gene mutation (Gly40Ser) with non-insulin-dependent diabetes mellitus.
Ristow M; Busch K; Schatz H; Pfeiffer A
Diabetes Res Clin Pract; 1996 May; 32(3):183-5. PubMed ID: 8858207
[TBL] [Abstract][Full Text] [Related]
11. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
Hansen LH; Abrahamsen N; Hager J; Jelinek L; Kindsvogel W; Froguel P; Nishimura E
Diabetes; 1996 Jun; 45(6):725-30. PubMed ID: 8635644
[TBL] [Abstract][Full Text] [Related]
12. Absence of the Gly40-ser mutation in the glucagon receptor gene in Japanese subjects with NIDDM.
Ogata M; Iwasaki N; Ohgawara H; Karibe S; Omori Y
Diabetes Res Clin Pract; 1996 Jul; 33(2):71-4. PubMed ID: 8879960
[TBL] [Abstract][Full Text] [Related]
13. Screening for the Gly40Ser mutation in the glucagon receptor gene among patients with type 2 diabetes or essential hypertension in Taiwan.
Huang CN; Lee KC; Wu HP; Tai TY; Lin BJ; Chuang LM
Pancreas; 1999 Mar; 18(2):151-5. PubMed ID: 10090412
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance.
Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Deeb SS
Diabetologia; 1995 May; 38(5):617-22. PubMed ID: 7489847
[TBL] [Abstract][Full Text] [Related]
15. Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity.
Echwald SM; Bjørbaek C; Hansen T; Clausen JO; Vestergaard H; Zierath JR; Printz RL; Granner DK; Pedersen O
Diabetes; 1995 Mar; 44(3):347-53. PubMed ID: 7883123
[TBL] [Abstract][Full Text] [Related]
16. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms.
Ura S; Araki E; Kishikawa H; Shirotani T; Todaka M; Isami S; Shimoda S; Yoshimura R; Matsuda K; Motoyoshi S; Miyamura N; Kahn CR; Shichiri M
Diabetologia; 1996 May; 39(5):600-8. PubMed ID: 8739921
[TBL] [Abstract][Full Text] [Related]
17. Amino acid substitutions in hexokinase II among patients with NIDDM.
Laakso M; Malkki M; Deeb SS
Diabetes; 1995 Mar; 44(3):330-4. PubMed ID: 7883120
[TBL] [Abstract][Full Text] [Related]
18. Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM.
Yamada K; Yuan X; Ishiyama S; Shoji S; Kohno S; Koyama K; Koyanagi A; Koyama W; Nonaka K
Diabetes Care; 1998 May; 21(5):753-6. PubMed ID: 9589236
[TBL] [Abstract][Full Text] [Related]
19. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.
Tao T; Tanizawa Y; Matsutani A; Matsubara A; Kaneko T; Kaku K
Diabetologia; 1995 Aug; 38(8):942-7. PubMed ID: 7589880
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM.
Huang XH; Rantalaiho V; Wirta O; Pasternack A; Koivula T; Hiltunen T; Nikkari T; Lehtimäki T
Hum Genet; 1998 Mar; 102(3):372-8. PubMed ID: 9544854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
